Thermo Fisher Opens US Bioprocess Center to Boost Biologics
WALTHAM, Massachusetts, USA, April 28, 2026 Thermo Fisher Scientific has announced the opening of its flagship U.S. Bioprocess Design...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
WALTHAM, Massachusetts, USA, April 28, 2026 Thermo Fisher Scientific has announced the opening of its flagship U.S. Bioprocess Design...
TEL AVIV, Israel & OSLO, Norway, April 28, 2026 BioLineRx and Hemispherian have announced that the first patient has...
WELLINGTON, New Zealand & KINGSTON, Canada, April 7, 2026 BioOra Limited and Octane Biotech Inc. announced a strategic Letter...
WINNIPEG, Manitoba – February 26, 2026 Emergent BioSolutions (NYSE: EBS) has announced approximately $140 million CAD in multiyear contract...
College Park, MD, December 1, 2025 — IonQ has announced a strategic partnership with CCRM to accelerate the development...
MENLO PARK, CA — November 20, 2025 — Antheia announced a strategic partnership with TAPI (Teva Active Pharmaceutical Ingredients)...
Vancouver, British Columbia & Rehovot, Israel — October 30, 2025 — BioHarvest Sciences Inc. (NASDAQ: BHST) has announced a...
